european commission

European Commission Statement on BioNTech-Pfizer top-up for Quarter 2 deliveries

Gespeichert von Fox am Di., 16.03.2021 - 13:51

The Commission and BioNTech-Pfizer have come to an agreement on the accelerated delivery of 10 million doses for Quarter 2. Commission President Ursula von der Leyen said: “I know how critical Quarter 2 is for the roll-out of our vaccination strategies in the Member States. These accelerated 10 million doses will bring the total doses of BioNTech-Pfizer in Quarter 2 up to over 200 million. This is very good news. It gives Member States room to manoeuvre and possibly fill gaps in deliveries.”